BioNTech's CEO said there's a 'relatively high' possibility the vaccine they made with Pfizer will protect against the UK's new coronavirus variant

BioNTech's CEO said there's a 'relatively high' possibility the vaccine they made with Pfizer will protect against the UK's new coronavirus variant

Business Insider

Published

The CEO said it will take around two weeks to get data from experiments that can show definitively whether the vaccine works against the new variant.

Full Article